User:Sabbachina96/sandbox

Heremos is a spinoff of Università Campus Bio-Medico di Roma focused on enhancing healthcare through innovative wearable technology and advanced data analytics. Founded in Italy, Heremos leverages proprietary wearable devices to collect, aggregate, and analyze physiological data, supporting pharmaceutical companies and healthcare facilities in delivering more effective and safer treatments.

History
Heremos was founded in Rome, Italy, with the vision of revolutionizing healthcare through the integration of wearable technology and data analytics. The organization began by developing proprietary wearable devices designed for continuous monitoring of physiological data. These devices, equipped with medical-grade biosensors, collect high-resolution data which is then analyzed using certified algorithms. This approach allows for the creation of patient-specific baselines and the detection of clinical deviations, significantly enhancing the accuracy and efficacy of clinical trials.

In its early years, Heremos focused on partnerships with pharmaceutical companies and healthcare facilities to implement its technology in real-world settings. One of the notable early projects was a study in Sicily involving 100 community pharmacists and 1,000 patients with COPD and asthma. This project utilized Heremos' smart bands for remote monitoring, providing deep analytics on patient health and significantly improving therapeutic adherence.

Heremos has continued to expand its reach and impact by developing new clinical indicators and biomarkers through customized data analysis. The organization’s innovative approach has positioned it at the forefront of data-driven healthcare, continually working towards improving patient outcomes and accelerating drug research. By integrating continuous data collection with advanced analytics, Heremos has been able to provide valuable insights into patient health, making therapies safer and more effective. The organization's commitment to innovation and collaboration with healthcare providers has made it a key player in the field of wearable health technology.

In 2023 Heremos has been included in the top 100 start-up from StartupItalia! .

In 2024 it has been selected for partecipating to both SMAU London and SMAU San Francisco.

Mission and Goals
The mission of Heremos is to enhance patient outcomes by integrating wearable technology with advanced data analytics. Key goals include:
 * Accelerating drug research
 * Improving the safety and efficacy of therapies
 * Enhancing patient monitoring outside of traditional healthcare settings
 * Collect pivotal raw data to develop digital twins and foundation models

Activities
Heremos engages in various activities, including:
 * Development of medical-grade biosensors for continuous monitoring
 * Analysis of physiological data to extract vital parameters and detect clinical deviations
 * Custom data analysis for new clinical indicators and biomarkers

Governance
The organization is led by key individuals including Alessandro Di Tomaso (CEO) and his sister Giulia Di Tomaso (CTO) and supported by an advisory board made up of professors from Università Campus Bio-Medico di Roma.

Partnerships
Heremos collaborates with various organizations, including community pharmacies and healthcare providers, to implement its technology and programs.